Chemed (CHE) Projected to Post Quarterly Earnings on Wednesday

Chemed (NYSE:CHE) is projected to issue its quarterly earnings data after the market closes on Wednesday, April 23rd. Analysts expect the company to announce earnings of $5.59 per share and revenue of $641.78 million for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

Chemed Price Performance

CHE opened at $580.52 on Monday. Chemed has a 1 year low of $512.12 and a 1 year high of $623.61. The stock’s 50 day simple moving average is $586.31 and its 200 day simple moving average is $567.45. The firm has a market cap of $8.48 billion, a price-to-earnings ratio of 29.33, a PEG ratio of 2.15 and a beta of 0.49.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 0.34%. The ex-dividend date of this dividend was Monday, February 24th. Chemed’s payout ratio is 10.05%.

Insider Activity at Chemed

In related news, CEO Kevin J. Mcnamara sold 1,000 shares of the stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $615.33, for a total value of $615,330.00. Following the completion of the transaction, the chief executive officer now directly owns 101,679 shares of the company’s stock, valued at $62,566,139.07. This represents a 0.97 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 3.32% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the stock. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th. Royal Bank of Canada raised their target price on Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a research note on Friday, March 14th.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.